(1)
Potential of Flavonoid Compounds from Etlingera Elatior Against Estrogen Receptor Alpha (ER+) As an Anti-Breast Cancer in Silico. J. Trop. Pharm. Chem 2025, 31-39. https://doi.org/10.30872/jtpc.v9i1.289.